Abstract
Background: The effects of hydrogen-rich water on PI3K/AKT-mediated apoptosis were studied in rats subjected to myocardial ischemia-reperfusion injury (MIRI).
Methdos: Sixty rats were divided randomly into a hydrogen-rich water group and a control group. The hearts were removed and fixed in a Langendorff device. Hearts from the control group were perfused with K-R solution, and hearts from the hydrogen-rich water group was perfused with K-R solution + hydrogen-rich water. The two treatment groups were then divided randomly into pre-ischemic period, ischemic period and reperfusion period groups(10 rats per group), which were subjected to reverse perfusion for 10 min, normal treatment for 20 min, and reperfusion for 20 min, respectively. The mRNA and protein expression levels of PI3K, AKT, p-AKT, FoxO1, Bim and Caspase-3 in each group were detected by RT-qPCR, immunohistochemistry (IHC) and Western blotting. Caspase-3 activity was detected by spectrophotometry. Results: Among the hydrogen-rich water group, the PI3K/AKT signaling pathway was significantly activated, and FoxO1, Bim, and Caspase-3 mRNA and protein levels were significantly decreased in ischemia-reperfusion subgroup compared with the preischemic and ischemic subgroups. In the ischemia-reperfusion hydrogen-rich water group, PI3K, AKT and p-AKT mRNA and protein expression levels were increased while the FoxO1, Bim and Caspase-3 expression levels were significantly decreased compared with those in the corresponding control group (P<0.05). Conclusion: Hydrogen-rich water can activate the PI3K/AKT signaling pathway, alleviate ischemia-reperfusion injury in isolated rat hearts, and inhibit cardiomyocyte apoptosis.Keywords: Hydrogen-rich water, myocardial ischemia-reperfusion injury, PI3K/AKT signaling pathway, FoxO1, Bim, Caspase-3, cardiomyocyte apoptosis.
[1]
Kurian GA, Rajagopal R, Vedantham S, Rajesh M. The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited. Oxid Med Cell Longev 2016. 1656450 2016
[2]
Ghavami S, Gupta S, Ambrose E, Hnatowich M, Freed DH, Dixon IM. Autophagy and heart disease: implications for cardiac ischemia-reperfusion damage. Curr Mol Med 2014; 14(5): 616-29.
[3]
Xin L, Junhua W, Long L, Jun Y, Yang X. Exogenous Hydrogen Sulfide Protects SH-SY5Y Cells from OGD/RInduced Injury. Curr Mol Med 2017; 17(8): 563-7.
[4]
Donato M, Evelson P, Gelpi RJ. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning. Curr Opin Cardiol 2017; 32(6): 784-90.
[5]
Huang C, Wang J, Wang N, et al. Effect of myocardial ischemic preconditioning on ischemia-reperfusion stimulation-induced activation in rat thoracic spinal cord with functional MRI. Int J Cardiol 2019; 285: 59-64.
[6]
Mentias A, Mahmoud AN, Elgendy IY, et al. Ischemic postconditioning during primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2017; 90(7): 1059-67.
[7]
Zhang Y, Long Z, Xu J, et al. Hydrogen inhibits isoproterenol‑induced autophagy in cardiomyocytes in vitro and in vivo. Mol Med Rep 2017; 16(6): 8253-8.
[8]
Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther 2014; 144(1): 1-11.
[9]
Zhai X, Chen X, Lu J, et al. Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. Mol Med Rep 2017; 15(3): 1305-12.
[10]
Ostojic SM. Molecular hydrogen in sports medicine: new therapeutic perspectives. Int J Sports Med 2015; 36(4): 273-9.
[11]
Terawaki H, Zhu WJ, Matsuyama Y, et al. Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients. Hemodial Int 2014; 18(2): 459-66.
[12]
Ishibashi T, Ichikawa M, Sato B, et al. Improvement of psoriasis-associated arthritis and skin lesions by treatment with molecular hydrogen: A report of three cases. Mol Med Rep 2015; 12(2): 2757-64.
[13]
Liu Q, Li BS, Song YJ, et al. Hydrogen-rich saline protects against mitochondrial dysfunction and apoptosis in mice with obstructive jaundice. Mol Med Rep 2016; 13(4): 3588-96.
[14]
Bai X, Liu S, Yuan L, et al. Hydrogen-rich saline mediates neuroprotection through the regulation of endoplasmic reticulum stress and autophagy under hypoxia-ischemia neonatal brain injury in mice. Brain Res 2016; 1646: 410-7.
[15]
Tian R, Hou Z, Hao S, et al. Hydrogen-rich water attenuates brain damage and inflammation after traumatic brain injury in rats. Brain Res 2016; 1637: 1-13.
[16]
Du H, Sheng M, Wu L, et al. Hydrogen-Rich Saline Attenuates Acute Kidney Injury After Liver Transplantation via Activating p53-Mediated Autophagy. Transplantation 2016; 100(3): 563-70.
[17]
Guo SX, Fang Q, You CG, et al. Effects of hydrogen-rich saline on early acute kidney injury in severely burned rats by suppressing oxidative stress induced apoptosis and inflammation. J Transl Med 2015; 13: 183.
[18]
Zeng K, Huang H, Jiang XQ, Chen XJ, Huang W. [Protective effects of hydrogen on renal ischemia/reperfusion injury in rats]. Sichuan Da Xue Xue Bao Yi Xue Ban 2014; 45(1): 39-42.
[19]
Song D, Liu X, Diao Y, et al. Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in rats. Mol Med Rep 2018; 18(2): 1925-38.
[20]
Kamimura N, Nishimaki K, Ohsawa I, Ohta S. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (Silver Spring) 2011; 19(7): 1396-403.
[21]
Zheng Y, Zhu D. Molecular Hydrogen Therapy Ameliorates Organ Damage Induced by Sepsis. Oxid Med Cell Longev 2016; 2016 5806057
[22]
Fu J, Zou J, Chen C, Li H, Wang L, Zhou Y. Hydrogen molecules (H2) improve perfusion recovery via antioxidant effects in experimental peripheral arterial disease. Mol Med Rep 2018; 18(6): 5009-15.
[23]
Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007; 13(6): 688-94.
[24]
Li X, Li L, Liu X, et al. Attenuation of cardiac ischaemia-reperfusion injury by treatment with hydrogen-rich water. Curr Mol Med 2019; 19(4): 294-302.
[25]
Chin KY, Qin C, May L, Ritchie RH, Woodman OL. New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury. Curr Drug Targets 2017; 18(15): 1689-711.
[26]
Ibáñez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 2015; 65(14): 1454-71.
[27]
Liu L, Jin X, Hu CF, Li R, Zhou Z, Shen CX. Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways. Cell Physiol Biochem 2017; 43(1): 52-68.
[28]
Dimitrova V, Arcaro A. Targeting the PI3K/AKT/mTOR signaling pathway in medulloblastoma. Curr Mol Med 2015; 15(1): 82-93.
[29]
Xuan F, Jian J, Lin X, et al. 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone Ameliorates Myocardial Ischemia/Reperfusion Injury in Rat by Inhibiting Apoptosis and Autophagy Via the PI3K-Akt Signal Pathway. Cardiovasc Toxicol 2017; 17(1): 79-87.
[30]
Wang D, Zhang X, Li D, et al. Kaempferide Protects against Myocardial Ischemia/Reperfusion Injury through Activation of the PI3K/Akt/GSK-3β Pathway. Mediators Inflamm 2017; 2017 5278218
[31]
Shu L, Zhang W, Huang C, Huang G, Su G. Troxerutin Protects Against Myocardial Ischemia/Reperfusion Injury Via Pi3k/Akt Pathway in Rats. Cell Physiol Biochem 2017; 44(5): 1939-48.
[32]
Tang L, Mo Y, Li Y, et al. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. Biochem Biophys Res Commun 2017; 486(3): 774-80.
[33]
Xin Z, Ma Z, Jiang S, et al. FOXOs in the impaired heart: New therapeutic targets for cardiac diseases. Biochim Biophys Acta Mol Basis Dis 2017; 1863(2): 486-98.
[34]
Coomans de Brachène A, Demoulin JB. FOXO transcription factors in cancer development and therapy. Cell Mol Life Sci 2016; 73(6): 1159-72.
[35]
Pallauf K, Duckstein N, Hasler M, Klotz LO, Rimbach G. Flavonoids as Putative Inducers of the Transcription Factors Nrf2, FoxO, and PPARγ. Oxid Med Cell Longev 2017; 2017 4397340
[36]
Crossland H, Constantin-Teodosiu D, Gardiner SM, Greenhaff PL. Peroxisome proliferator-activated receptor γ agonism attenuates endotoxaemia-induced muscle protein loss and lactate accumulation in rats. Clin Sci (Lond) 2017; 131(13): 1437-47.
[37]
Mortzfeld BM, Bosch TC. Eco-Aging: stem cells and microbes are controlled by aging antagonist FoxO. Curr Opin Microbiol 2017; 38: 181-7.
[38]
Konstantakou EG, Voutsinas GE, Velentzas AD, et al. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants. Mol Cancer 2015; 14: 135.
[39]
Shukla S, Sharma A, Pandey VK, Raisuddin S, Kakkar P. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells. Toxicol Appl Pharmacol 2016; 291: 70-83.
[40]
Shukla S, Saxena S, Singh BK, Kakkar P. BH3-only protein BIM: An emerging target in chemotherapy. Eur J Cell Biol 2017; 96(8): 728-38.
[41]
Sionov RV, Vlahopoulos SA, Granot Z. Regulation of Bim in Health and Disease. Oncotarget 2015; 6(27): 23058-134.
[42]
Song HM, Song JL, Li DF, Hua KY, Zhao BK, Fang L. Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway. OncoTargets Ther 2015; 8: 3565-73.
[43]
Ravindran S, Kurian GA. The role of secretory phospholipases as therapeutic targets for the treatment of myocardial ischemia reperfusion injury. Biomed Pharmacother 2017; 92: 7-16.